Systematic review of efficacy and meta-analysis of safety of ranibizumab biosimilars relative to reference ranibizumab anti-VEGF therapy for nAMD treatment. - Hatamnejad A; Dadak R; Orr S; Wykoff C; Choudhry N (BMJ open ophthalmology, 2023)